Search results
Order by most recent / most popular / relevance
Results: 1-6 of 6
FDA issues warning letter to Lancôme for anti-aging claims
- Sidley Austin LLP
- -
- USA
- -
- September 14 2012
On September 7, 2012, the compliance office within the Center for Food Safety and Applied Nutrition (CFSAN) at FDA issued a Warning Letter to Lancôme USA, a subsidiary of L’Oréal, regarding several anti-aging skin care products being marketed as cosmetics
Appeals Court issues important ruling in fraud and abuse case involving individual liability
- Sidley Austin LLP
- -
- USA
- -
- July 31 2012
A recent D.C. Circuit decision in Friedman v. Sebelius overturned the exclusions of three Purdue pharma executives from participation in federal healthcare programs, holding that the Department of Health and Human Services acted arbitrarily in imposing extraordinarily lengthy exclusions
CMS seeks comments on its long-awaited Sunshine Act proposed rule
- Sidley Austin LLP
- -
- USA
- -
- December 21 2011
The Centers for Medicare & Medicaid Services recently published a proposed rule implementing the Physician Payment Sunshine Act (section 6002 of the Affordable Care Act
Recent SFDA and MOH new developments
- Sidley Austin LLP
- -
- USA
- -
- January 21 2011
The State Food and Drug Administration ("SFDA, the Agency") issued an order in late December 2010 to require compulsory incorporation of a monitoring bar code issued by the agency in the direct packaging materials of compound pharmaceutical formulations containing ephedrine, codeine and diphenoxylate, in order to prevent abuse and misuse of such products
Senate passes food safety legislation: food product and dietary supplement implications
- Sidley Austin LLP
- -
- USA
- -
- December 7 2010
On November 30, 2010, the Senate approved the long-awaited Food Safety Modernization Act, S. 510, by a 73-25 vote
FDA draft guidance on Dear Health Care Provider letters carries potentially significant products liability implications
- Sidley Austin LLP
- -
- USA
- -
- November 19 2010
The Food and Drug Administration (FDA) draft Guidance (Guidance) addressing the content and format of Dear Health Care Provider (DHCP) letterswhich are sometimes called "Dear Doctor" lettersis the first substantive guidance from FDA on this issue
Current Search
- Workarea - Healthcare
- Workarea - Product Liability
- Firm Name - Sidley Austin LLP
- Author - Scott Bass
- Jurisdiction - USA